Several stocks are expect to remain in focus due to multiple reasons like stake transfer, orders, regulatory notices etc.

Investors are expected to remain cautious due to uncertainty over US tariff threats and global market reactions.

Sun Pharmaceuticals will acquire Checkpoint Therapeutics for $355 million, bringing the FDA-approved anti-PD-L1 treatment for ...

WASHINGTON (AP) — Most of the 80,000 federal workers responsible for researching diseases, inspecting food and administering ...

Shares of firms like HCL Tech, RailTel, Tata Power, IndusInd Bank, Gensol, and others will be in focus on Monday's trade ...